Luye Pharma Group Ltd 2025 Annual Report
Company: Luye Pharma Group Ltd
Sector: Manufacturing
Country: China
Year: 2025
Type: Annual Report
Pages: 190
The report presents the Group's 2025 performance, with revenue of RMB6,308.4 million and EBITDA of RMB2,470.7 million. It describes a portfolio of over 30 products operating across more than 80 countries and regions. The Group employed 5,221 people at year-end. Its governance disclosures identify board-level ESG oversight and report two female directors on the 11-member Board.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.